FDA unveils guidance for ‘plug and play’ gene therapies

T2Covered by 1 source · first reported by BioPharma Dive / Healthcare Dive / MedTech Dive at 28 Oct, 15:15 UTC

The plan advances recent agency moves to accelerate “personalized” treatments by offering an approval framework for therapies that can benefit different subsets of patients with the same disease.

devscience

Sources

• T2FDA unveils guidance for ‘plug and play’ gene therapiesBioPharma Dive / Healthcare Dive / MedTech Dive28 Oct, 15:15